Investor Relations

Press Releases

General Releases
  REVA Financing Completed -- Receipt of US$13.3 Million
Jun 19, 2017
PDF 145.9 KB Add to Briefcase
  REVA Symposium Showcases Clinical Data
May 17, 2017
PDF 180.7 KB Add to Briefcase
  REVA Announces Positive 12-Month Clinical Results
May 16, 2017
PDF 149.8 KB Add to Briefcase
  Notice of Briefing Call
Apr 27, 2017
PDF 136.7 KB Add to Briefcase
  REVA Arranges Convertible Note Financing
Apr 24, 2017
PDF 148.6 KB Add to Briefcase
  REVA to Present at EuroPCR 2017
Apr 11, 2017
PDF 152.6 KB Add to Briefcase
  REVA Receives CE Mark for Fantom
Apr 3, 2017
PDF 151.1 KB Add to Briefcase
  REVA to Expand FANTOM II Trial to More Complex Cases
Mar 23, 2017
PDF 153.3 KB Add to Briefcase
  Notice of Briefing Call
Mar 8, 2017
PDF 137.1 KB Add to Briefcase
  REVA Medical to Present at J.P. Morgan Healthcare Conference
Jan 9, 2017
PDF 136.3 KB Add to Briefcase
  REVA to Hold Briefing Call on Q3 2016 Financial Results
Nov 2, 2016
PDF 138.9 KB Add to Briefcase
  REVA Releases Positive Data for Fantom at TCT
Oct 31, 2016
PDF 153.2 KB Add to Briefcase
  REVA to Present at TCT 2016
Oct 24, 2016
PDF 154.1 KB Add to Briefcase
  REVA to Hold Briefing Call on Q2 2016 Financial Results
Aug 10, 2016
PDF 137.2 KB Add to Briefcase
  REVA Completes Submission of CE Mark Application
Aug 2, 2016
PDF 152.2 KB Add to Briefcase
  REVA Sponsors Symposium at EuroPCR 2016
May 18, 2016
PDF 182.6 KB Add to Briefcase
  REVA Releases Positive Clinical Results for Fantom
May 17, 2016
PDF 182.9 KB Add to Briefcase
  REVA to Present at EuroPCR 2016
May 10, 2016
PDF 163.2 KB Add to Briefcase
  Details for REVA's Annual Meeting
May 9, 2016
PDF 156.9 KB Add to Briefcase
  Brian Dovey Elected Chairman
Mar 29, 2016
PDF 37.6 KB Add to Briefcase
Showing 1-20 of 102 Page: 1 2 3 4 5 6  Next 20
Add to Briefcase = add release to Briefcase